EHA 2022 Conference Coverage
EHA 2022 CD47 Targeting in HR-MDS: Surveying Clinical Data for Magrolimab
By
EHA 2022 Conference Coverage
FEATURING
David Sallman
August 4, 2022
Login to view comments.
Click here to Login
